Louis Moore Bacon's TMCI Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 222,110 shares of Treace Medical Concepts, Inc. (TMCI) worth $544,170, representing 0.01% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Louis Moore Bacon has initiated a new position in TMCI, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 74,503 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Treace Medical Concepts (TMCI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Treace Medical Concepts (TMCI) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +74,503 | Add 50.47% | 222,110 | $2.45 |
| Q3 2025 | +147,607 | New Buy | 147,607 | $6.71 |
Louis Moore Bacon's Treace Medical Concepts Investment FAQs
Louis Moore Bacon first purchased Treace Medical Concepts, Inc. (TMCI) in Q3 2025, acquiring 147,607 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Treace Medical Concepts, Inc. (TMCI) for 2 quarters since Q3 2025.
Louis Moore Bacon's largest addition to Treace Medical Concepts, Inc. (TMCI) was in Q3 2025, adding 147,607 shares worth $990,443.
According to the latest 13F filing for Q4 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 222,110 shares of Treace Medical Concepts, Inc. (TMCI), valued at approximately $544,170.
As of the Q4 2025 filing, Treace Medical Concepts, Inc. (TMCI) represents approximately 0.01% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Treace Medical Concepts, Inc. (TMCI) was 222,110 shares, as reported at the end of Q4 2025.